相关实验视频

Updated: May 6, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

新兴的纳米载体设计用于增强多克索鲁比的输送

Weibo Kong¹, Weijun Chen^1,2, Jing Hui³

¹School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, China.

Nanomedicine (London, England)

|July 4, 2025

概括

新型纳米载体通过向瘤微环境 (TME) 来增强多克索鲁比 (DOX) 化疗. 这些策略克服了DOX的毒性,并改善了抗瘤效应,以改善癌症治疗.

科学领域:

在瘤学瘤学.
纳米技术纳米技术
药理学药理学是指药理学的学科.

背景情况:

多克索鲁比 (DOX) 是一种重要的化疗药物,但由于心脏毒性,多药耐药性和全身毒性而面临限制.
基于纳米载体的药物输送系统通过改善瘤积累和减轻非目标效应,提供了潜在的解决方案.
瘤微环境 (TME) 在癌症进展和治疗耐药性方面发挥着关键作用,需要新的向策略.

研究的目的:

审查基于纳米载体的多克索鲁比辛输送系统的最新进展.
突出重点关注瘤微环境 (TME) 重编程和免疫调节的战略.
评估新型平台,提高抗瘤疗效,减少多克索鲁比的剂量限制性毒性.

主要方法:

2019-2022年对多克索鲁比装载纳米载体的系统文献综述.
分析纳米载体设计创新,包括刺激响应释放和分子识别向.
评估TME重编程方法,例如细胞外矩阵调制.

主要成果:

纳米载体可以被设计为增强瘤向和控制药物释放.
刺激响应系统和分子向提高了药物输送的特异性.
TME调节策略在克服治疗耐药性和增强多克索鲁比的疗效方面表现有前途.
最近的研究重点是针对协同抗瘤效应的组合方法.

结论:

先进的纳米载体设计为克服多克索鲁比的局限性提供了巨大的潜力.
向瘤微环境是改善化疗结果的关键策略.
未来的研究应该专注于开发复杂的纳米输送平台,以加强癌症治疗.

关键词:

德克索鲁比辛是一种多克索鲁比辛.癌症癌症癌症癌症癌症药物输送是药物输送的过程.纳米载体的纳米载体瘤微环境是一个微环境.

更多相关视频

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...